MegaMD Co Stock

MegaMD Co Equity

The The Equity of MegaMD Co (133750.KQ) as of Aug 26, 2026 is 66.39 B KRW. In the previous year, The Equity was 65.78 B KRW — a change of 0.93% (higher).

Equity

66.39 BKRW

YoY

0.93%

Last updated:

In 2026, MegaMD Co's equity was 66.39 B KRW, a 0.93% increase from the 65.78 B KRW equity in the previous year.

The MegaMD Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
58.05 B KRW
Jan 1, 2019
57.36 B KRW
Jan 1, 2020
61.90 B KRW
Jan 1, 2021
66.60 B KRW
Jan 1, 2022
65.74 B KRW
Jan 1, 2023
62.24 B KRW
Jan 1, 2024
65.78 B KRW
Jan 1, 2025
66.39 B KRW
The MegaMD Co Equity history
YEAREquityYoY
66.39 BKRW+0.93%
65.78 BKRW+5.68%
62.24 BKRW-5.32%
65.74 BKRW-1.28%
66.60 BKRW+7.58%
61.90 BKRW+7.92%
57.36 BKRW-1.19%
58.05 BKRW-0.04%
58.08 BKRW-7.89%
63.05 BKRW+3.69%
60.80 BKRW+50.98%
40.27 BKRW—
Access this data via the Eulerpool API
Get Free API Key

MegaMD Co Stock analysis

What does MegaMD Co do? MegaMD Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing MegaMD Co's Equity

MegaMD Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding MegaMD Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating MegaMD Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

MegaMD Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in MegaMD Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about MegaMD Co stock

The Equity of MegaMD Co is 66.39 B KRW in 2026.

The Equity of MegaMD Co changed from 65.78 B KRW to 66.39 B KRW, representing a 0.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity MegaMD Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's MegaMD Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — MegaMD Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — MegaMD Co